Key Takeaways & Executive Findings
- •• Super-resolution imaging reveals that apparent gaps at common fragile sites (CFSs) are filled with chromatin resembling mitotic nanodomains (MNDs) but lacking compact granules (CGs). • Mitotic DNA synthesis (MiDAS) loci exhibit only MND-level organization, indicating a structural deficiency in higher-order chromatin assembly at CFSs. • This study provides the first ultrastructural characterization of CFSs and MiDAS loci, linking replication stress to specific chromatin architecture defects. • The findings suggest that failure to progress from MNDs to CGs may underlie genomic instability at CFSs, offering new insights into carcinogenesis and developmental disorders.
Abstract
Common fragile sites (CFSs) are large genomic loci that are frequently deleted under replication stress and are thought to play a role in carcinogenesis as well as developmental disorders during early embryogenesis. They often appear as gaps or breaks in mitotic chromosomes by conventional optical microscopy and are also loci that are replicated in mitosis in a process called mitotic DNA synthesis (MiDAS). However, we still have a very poor understanding of the potential mechanisms underlying their genomic instability. We recently found that in normal mitotic chromosomes, there is a two-level hierarchy in the higher-order chromatin structure, with mechanically resistant ~90 nm Mitotic NanoDomains (MNDs) assembling into ~125 nm compact granules (CGs). In this work, we combine multiple super-resolution imaging techniques, including binding-activated localization microscopy (BALM), atomic force microscopy (AFM), and stochastic optical reconstruction microscopy (STORM), to characterize CFSs. Our super-resolution data indicate that sites that appear as gaps by conventional microscopy can be filled with chromatin of the size and shape of MNDs but not CGs. Moreover, we find that MiDAS loci only form an array of MNDs with no CGs. Taken together, our work suggests that under replication stress, CFS loci can not only be replicated but also assembled into higher-order chromatin. However, this organization is limited to the level of MNDs, which suggests that a failure to progress beyond MNDs to form CGs constitutes a key structural deficiency at these loci.
1. Introduction
To maintain their proper functioning, eukaryotic cells must faithfully duplicate their genomic DNA and accurately fold their chromatin during the cell cycle. However, this can be significantly challenging, as cells often encounter various forms of replication stress from both exogenous and endogenous sources [1]. These stresses can lead to a wide range of chromosomal alterations, from single- or few-base pair mutations to larger changes that span hundreds to millions of base pairs that can likewise lead to significant changes in cell behavior [2–5]. However, how precisely these replication stresses lead to such changes, particularly those that span incredibly large genomic regions, is very poorly understood.
Arguably, the best characterized large-scale changes occur at so-called common fragile sites (CFSs) [6]. These regions, which can be up to a few mega base pairs in length, frequently form cytogenetically defined chromosomal gaps or breaks in G-banding assays under replication stress [6,7]. Importantly, CFSs are known to frequently overlap with chromosomal breakpoints in many cancers, where they are hotspots for chromosomal rearrangements, contributing to tumor development and progression [8,9]. In addition, large-scale changes in CFSs are also found in the embryo during development, perhaps owing to replication stress during the rapid cell division of early embryogenesis [10,11]. However, despite these observations, it is not understood how replication stress leads to deletions, rearrangements, or any particular manifestation of genomic changes at CFSs.
Loading authentic research manuscript (Pages 1–5)...
Jiabin Wang, Daniel M. Czajkowsky, Zhifeng Shao (2026). Super-resolution imaging reveals higher-order structures within common fragile sites in human mitotic chromosomes. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2026014
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What are common fragile sites (CFSs) and why are they important?
Common fragile sites are specific genomic loci that are prone to breakage under replication stress. They are associated with chromosomal rearrangements in cancers and developmental disorders, making them critical for understanding genomic instability.
What super-resolution techniques were used in this study?
The study employed binding-activated localization microscopy (BALM), atomic force microscopy (AFM), and stochastic optical reconstruction microscopy (STORM) to visualize chromatin structure at nanometer resolution.
What did the super-resolution imaging reveal about CFSs?
The imaging revealed that apparent gaps at CFSs are actually filled with chromatin organized into mitotic nanodomains (MNDs) but lacking compact granules (CGs), indicating a partial higher-order structure.
What is mitotic DNA synthesis (MiDAS) and how does it relate to CFSs?
MiDAS is a process where DNA replication occurs during mitosis to complete replication of under-replicated regions, often at CFSs. The study found that MiDAS loci also exhibit only MND-level organization, suggesting a structural deficiency.
What are the potential implications of this research?
The findings suggest that failure to form compact granules at CFSs may contribute to genomic instability, providing new insights into cancer development and potential therapeutic targets.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.